Mirtazapine Augmentation: Running Low on Rocket Fuel
The Carlat Psychiatry Report, Volume 17, Number 9, September 2019
https://www.thecarlatreport.com/newsletter-issue/tcprv17n9/
Issue Links: Learning Objectives | Editorial Information
Topics: Antidepressant Augmentation | Antidepressants | Depression | Depressive Disorder | Mirtazapine | Pharmacology | Pharmacology Tips | Psychopharm Myths | Psychopharmacology | Psychopharmacology Tips | SSRIs | Treatment-Resistant Depression | Venlafaxine
Thomas Jordan, MD and Chris Aiken, MD.
Dr. Jordan and Dr. Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dubbed “California Rocket Fuel” by Stephen Stahl, the combination of venlafaxine and mirtazapine seemed to hit all the right receptors. The hype may have gotten a little ahead of the evidence on this one, however, as three new studies reveal.
You can't view details of this content, please login or buy subscription here